Mostrar el registro sencillo del ítem

dc.contributor.authorPalau, Patricia
dc.contributor.authorDomínguez Mafé, Eloy
dc.contributor.authorLópez, Laura
dc.contributor.authorHeredia, Raquel
dc.contributor.authorGonzález, Jessika
dc.contributor.authorRamón, José María
dc.contributor.authorSerra, Pilar
dc.contributor.authorSantas, Enrique
dc.contributor.authorBodí, Vicent
dc.contributor.authorSanchis, Juan
dc.contributor.authorChorro, Francisco J.
dc.contributor.authorNúñez, Julio
dc.date.accessioned2017-01-09T12:56:56Z
dc.date.available2017-01-09T12:56:56Z
dc.date.issued2016-08-02
dc.identifier.citationPALAU SAMPIO, Patricia; DOMÍMNGUEZ MAFÉ, Eloy; LÓPEZ, Laura; HEREDIA, Raquel; GONZÁLEZ, Jessika; RAMÓN, José María; SERRA, Pilar; SANTAS, Enrique; BODÍ, Vicent; SANCHIS, Juan; CHORRO, Francisco J.; NÚÑEZ, Julio. nspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial. Clinical Cardiology (2016), v. 39, p. 8, pp. 433-439ca_CA
dc.identifier.urihttp://hdl.handle.net/10234/165271
dc.description.abstractHeart failure with preserved ejection fraction (HFpEF) has become the most prevalent form of heart failure in developed countries. Regrettably, there is no evidence-based effective therapy for HFpEF. We seek to evaluate whether inspiratory muscle training, functional electrical stimulation, or a combination of both can improve exercise capacity as well as left ventricular diastolic function, biomarker profile, quality of life (QoL), and prognosis in patients with HFpEF. A total of 60 stable symptomatic patients with HFpEF (New York Heart Association class II–III/IV) will be randomized (1:1:1:1) to receive a 12-week program of inspiratory muscle training, functional electrical stimulation, a combination of both, or standard care alone. The primary endpoint of the study is change in peak exercise oxygen uptake; secondary endpoints are changes in QoL, echocardiogram parameters, and prognostic biomarkers. As of March 21, 2016, thirty patients have been enrolled. Searching for novel therapies that improve QoL and autonomy in the elderly with HFpEF has become a health care priority. We believe that this study will add important knowledge about the potential utility of 2 simple and feasible physical interventions for the treatment of advanced HFpEF.ca_CA
dc.description.sponsorShipThis work was supported in part by grants from Sociedad Española de Cardiología Investigación Clínica en Cardiología Grant SEC 2015; and Red de Investigación Cardiovascular; Programa 7 (RD12/0042/0010) and PIE15/00013.ca_CA
dc.format.extent7 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherWileyca_CA
dc.relation.isPartOfClinical Cardiology (2016), v. 39, p. 8ca_CA
dc.rights.urihttp://rightsstatements.org/vocab/CNE/1.0/*
dc.subjectHeart failure with preserved ejection fraction (HFpEF)ca_CA
dc.subjectDeveloped countriesca_CA
dc.subjectLeft ventricular diastolic functionca_CA
dc.subjectBiomarker profileca_CA
dc.subjectQuality of life (QoL)ca_CA
dc.titleInspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trialca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttp://dx.doi.org/10.1002/clc.22555
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_CA
dc.relation.publisherVersionhttp://onlinelibrary.wiley.com/doi/10.1002/clc.22555/abstract;jsessionid=9DED582568EB54A239BEC77CBA37AF59.f04t02ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem